載入...
Treatment of unresectable cutaneous squamous cell carcinoma with pembrolizumab
Currently, there are few effective therapies for locally advanced and metastatic cutaneous squamous cell carcinoma (cSCC); however, there is recent evidence supporting the use of immunological therapies in cSCC given the typically high mutation burden and association with immunosuppressed states. Th...
Na minha lista:
| 發表在: | BMJ Case Rep |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6685369/ https://ncbi.nlm.nih.gov/pubmed/31377718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-229915 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|